Cell Harvester Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

The Global Cell Harvester Market is expected to experience a compound annual growth rate (CAGR) of 6.61%, expanding from USD 3.78 billion in 2025 to USD 5.55 billion by 2031. These vital devices are built to effectively separate, gather, and process cells from biological materials for various therapeutic and research purposes. Market growth is primarily fueled by rising needs in regenerative medicine, a rapidly expanding biopharmaceutical sector, and the wider use of cell-based treatments for infectious and chronic conditions. Furthermore, progress in closed-system and automated technologies greatly improves processing precision and efficiency. The magnitude of the supporting industry is highlighted by the Biotechnology Innovation Organization (BIO), which estimated the wider bioscience product market at $1.7 trillion in 2025.

Despite these positive trends, market growth faces a major obstacle due to the steep expenses tied to cutting-edge cell harvesting equipment and related procedures. This financial barrier encompasses both the initial capital required for complex automated platforms and the ongoing operational costs for trained staff and specialized disposable materials.

Market Driver

The Global Cell Harvester Market is largely driven by the rapid growth of cell therapies and regenerative medicine. These cutting-edge treatments rely heavily on effective cell harvesting techniques to isolate and process specific cells for combating diseases. The need for dependable and adaptable cell processing methods grows stronger as an increasing number of gene and cell therapies move toward clinical trials and regulatory clearance. Ensuring optimal cell purity and survival, harvesters are indispensable for readying cells for transplantation and infusion. Emphasizing the massive pipeline in need of sophisticated processing tools, PhRMA reported that 438 gene and cell therapies were actively being developed in the United States as of January 2026.

The market is also heavily influenced by breakthroughs in single-use and automated technologies. Automation lowers contamination threats, boosts consistency, and cuts down on manual work, all of which are essential for producing delicate cell therapies. Utilizing single-use elements like disposable tubing and bags streamlines procedures, speeds up processing cycles, and mitigates cross-contamination hazards by removing the need for rigorous sterilization and cleaning. Showcasing a strong commitment to bioprocessing that aids cell harvesting, European Biotechnology Magazine noted in February 2026 that Sartorius dedicated EUR 442 million in 2025 to expand production in Asia and Europe. Additionally, Biocom reported in March 2026 that the life science industry saw a total deal value of $372 billion in 2025, reflecting the extensive sectoral expansion driving the need for new harvesting technologies.

Market Challenge

A major barrier to the growth of the Global Cell Harvester Market is the steep price of modern cell harvesting equipment and the corresponding procedural expenses. Buyers face heavy initial capital requirements to purchase the automated platforms needed for effective cell gathering and isolation. Moreover, the continuous operational costs tied to expert personnel, reagents, and specialized disposable supplies significantly increase the financial strain on users. Such steep economic requirements restrict wider market penetration, especially for academic labs, smaller research facilities, and nascent biopharmaceutical firms operating on tight budgets.

The massive financial scope of advanced therapies is reflected in the heavy investments needed throughout the regenerative medicine industry, directly affecting the uptake of niche devices like cell harvesters. The Alliance for Regenerative Medicine reported that the sector raised $11.1 billion through 216 financing rounds in 2025. High expenses associated with harvesting technologies form a major part of the capital needed to build and run research and manufacturing centers for cell therapies. Consequently, this financial reality hinders market expansion, forcing organizations to carefully balance large upfront costs against their operating budgets and expected returns.

Market Trends

Within the Global Cell Harvester Market, the growing robust pipeline of gene and cell therapies is creating a strong demand for high-throughput processing capabilities. This movement highlights the necessity to handle larger volumes of cell populations and samples at the same time, which greatly quickens the pace of research, development, and commercial manufacturing. High-throughput harvesting technologies facilitate smoother operational workflows, which are essential for scaling up effectively and maintaining uniformity across massive production batches. Illustrating this shift toward scaled operations, News on Projects highlighted in February 2026 that Cytiva launched a 30,000-square-foot bioprocessing plant in Bengaluru, India, aimed at speeding up biopharmaceutical drug development.

At the same time, cell harvesting is being revolutionized by the incorporation of digital monitoring systems and artificial intelligence, leading to better operational efficiency and accuracy. Moving away from standard manual checks, digital instruments and AI algorithms allow for the real-time assessment of optimal harvesting times, growth metrics, and overall cell health. By predicting process anomalies, lowering human error, and maximizing cell survival and yield, these advancements elevate the reproducibility and quality of the final product. Highlighting this trend, Emory University announced in December 2025 the implementation of a $1.5 million automated cell culture platform that uses AI to concurrently track and analyze 20,000 organoids for cell differentiation trends.

Key Market Players

• Human Med AG
• ADS Biotec Inc.
• PerkinElmer Inc.
• TERUMO BCT, INC.
• Esco Micro Pte. Ltd.
• Gasser Apparatebau und Laborzubehör
• Sartorius AG
• Cox Scientific Ltd.
• Pall Corporation

Report Scope

In this report, the Global Cell Harvester Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Harvester Market, By Type:

• Displacement Collector
• Therapy Collector

Cell Harvester Market, By Application:

• Cell Proliferation Assays
• Mixed Lymphocyte Culture (MLC) Assays
• Receptor-Binding Assays
• Single-Stranded Template DNA Harvesting
• Others

Cell Harvester Market, By Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Harvester Market.

Available Customizations

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.